TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES

The present invention relates to tumor targeted bispecific agonistic antigen binding molecules characterized by monovalent binding to CD28, methods for their production, pharmaceutical compositions containing these antibodies, and methods of using the same.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SAM, Johannes, HOSSE, Ralf, GEORGES, Guy, HOFER, Thomas, KLEIN, Christian, UMAÑA, Pablo, MOESSNER, Ekkehard, GASSER, Stephan, FAUTI, Tanja, THOM, Jenny Tosca, VALLIER, Jean-Baptiste Pierre
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to tumor targeted bispecific agonistic antigen binding molecules characterized by monovalent binding to CD28, methods for their production, pharmaceutical compositions containing these antibodies, and methods of using the same.